AUTOFLEET
Autofleet , a provider of AI-powered fleet optimization solutions, was selected by Keolis , a public transport operator, to provide its platform for an autonomous electric vehicle (AEV) project in Gothenburg, Sweden. Shuttle operation began on January 18, 2021 on behalf of local public transport authority Västtrafik. The autonomous shuttle service is the first project in an ongoing collaboration to utilize Autofleet’s platform for management of Keolis’ new mobility solutions.
The shuttle service, which is integrated into the city of Gothenburg’s public transportation network as line 56, will serve a route that covers industrial and residential sites using two autonomous electric shuttles manufactured by Navya. Designed to operate in conditions including sub-zero temperatures and snow, this autonomous electric shuttle service is the city’s most advanced mobility project to-date.
Autofleet’s platform aggregates and analyzes granular shuttle data through an integration with Navya’s API in real time to produce actionable insights for operators around the project’s performance. The interface tracks shuttles at the individual sensor level and continually provides data such as station and passenger usage, allowing Keolis to gain clear insights for optimization and improvement of the service. Automated notification and alerting capabilities keep the operational teams aware of field events as they occur. In addition, the Autofleet driver app allows safety operators to track and share reports with their team in a single interface.
Autofleet’s platform is agnostic to the vehicle manufacturer or vehicle type. For their continued work with Autofleet, Keolis is able to integrate autonomous shuttles and electric or internal combustion engine-powered vehicles into the platform, providing the transport operator with a single point of access for managing and scaling their deployments.
“Autofleet’s platform provides impactful data that allows us to measure KPIs, and in turn improve our toolkit of services for future projects,” said Scheherazade Zekri, Director of New Mobility Services at Keolis Group. “The company’s work with us is crucial for developing new autonomous shuttle services that better manage fleets and serve commuters.”
“Autofleet's goal is to implement sustainable mobility services and support the transition of asset heavy fleets to Vehicle as a Service providers.” said Kobi Eisenberg, CEO at Autofleet. “We are excited to partner with Keolis on this project in order to execute autonomous operations in extreme conditions serving the transportation needs of communities globally.”
Autofleet offers fleet owners and operators a platform to automate and optimize fleet management for organizations and has partnered with other global fleets and manufacturers including Avis Budget Group, Zipcar, Keolis and Suzuki. In April 2020, Autofleet announced a capital raise totaling $7.5 million from its Series A, led by MizMaa Ventures, and seed financing, led by Maniv Mobility.
About Autofleet
Autofleet provides the leading Vehicle-as-a-Service platform for fleets to optimize existing operations and to seamlessly launch new business models from existing assets. The platform leverages advanced machine-learning algorithms for demand prediction, optimized placement and matching, automated pit-stop management and in/de-fleeting, and more. For more information, please visit https://www.autofleet.io/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210317005879/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
Enry's Island SpA Strengthens Its Leadership in Venture Capital with Explosive Growth and Redesigns the Future of VC Through Gaming19.12.2025 00:34:00 CET | Press release
Announcement of Enry’s Island AdVentures: the world’s first video game to learn how to launch and scale startups, focused on democratizing innovation for “Long Tail Users” Enry’s Island SpA (WBAG:EIOS), the world’s first publicly listed venture builder, announces a new era of growth, innovation, and the democratization of Venture Capital (VC). The company has delivered exceptional results, consolidating its position as an industry leader through a strategic positioning in the rapidly expanding gaming market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218742236/en/ Record Growth and Performance Enry’s Island SpA has demonstrated an extraordinary growth trajectory and a strong financial and operational track record: Revenues: +250% year-over-year (YoY). Exit: $3.6M in exits realized via IPO. Portfolio: 1 IPO of a portfolio company completed in December 2024, with an additional 2 IPOs expected in 2026. The performance of
500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy18.12.2025 21:37:00 CET | Press release
Part of the Digital Morocco 2030 strategy, 500 Global has been selected to support the Startup Venture Building (Startup VB) initiative. 500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218363323/en/ Announcement of 500 Global's continued expansion across Africa and support of Digital Morocco 2030 Launched by the Ministry of Digital Transition and Administrative Reform (Ministry) and deployed by TAMWILCOM, the Startup VB initiative is a flagship program under the Digital Morocco 2030 strategy. Startup VB aims to streng
Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 17:00:00 CET | Press release
New capital accelerates Neural Concept’s ability to deliver transformative technologies and enterprise-wide AI impact across advanced industrial workflows.Platform delivers CAD-native, physics-aware AI and deep reasoning for engineering, saving customers $50 million annually, reducing late-stage redesigns by 30-50% and accelerating time to market by up to two years.The company has generated a fourfold increase in enterprise revenue over the past 18 months.More than 50 global companies are actively relying on the platform, including General Motors, General Electric Vernova, Leonardo Aerospace, Eaton, Safran, Renault Group and multiple Formula 1 teams. Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press
Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 16:57:00 CET | Press release
Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special?MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
